🎯Investment Objective
“An open-ended Equity Scheme investing in healthcare sector”
Source: Sbi Healthcare Opportunities Fund scheme information document
AI Summary
indian-fundStrengths1
- Expense ratio of 0.92% is below the category median of 0.93%
Concerns1
- High sector concentration — Pharmaceuticals & Biotechnology accounts for 66.0% of the portfolio
Rule-based from financial data. Not advice.
Asset Allocation
Sector Allocation
Holdings-Based Style Box
This fund sits in the Mid-Blend quadrant based on its holdings characteristics.
The fund primarily holds mid-cap stocks (ranked 101–250 by market cap) — offering a balance of growth potential and relative stability. The ‘Blend’ position means the portfolio mixes both value and growth stocks — a balanced approach.
📖 What do Large/Mid/Small Cap mean? →Key Metrics
Fund DNA
Portfolio Holdings35 positions
The Weight column shows how much of the fund's money is in each stock. The 3M Change reveals the fund manager's recent moves, increasing weight (↑ green) means they're buying more, decreasing (↓ red) means they're trimming. Click any stock name to see its detailed financials on Equiscale.
📖 Learn: Diversification & Asset Allocation →| # | Company | Sector | Allocation | Weight (%) | 3M Change |
|---|---|---|---|---|---|
| 1 | Sun Pharmaceutical Industries Ltd. | Pharmaceuticals & Biotechnology | 10.7% | - | |
| 2 | Divi's Laboratories Ltd. | Pharmaceuticals & Biotechnology | 7.5% | - | |
| 3 | Apollo Hospitals Enterprise Ltd. | Healthcare Services | 5.8% | - | |
| 4 | Max Healthcare Institute Ltd. | Healthcare Services | 4.8% | - | |
| 5 | Acutaas Chemicals Ltd. | Pharmaceuticals & Biotechnology | 4.8% | - | |
| 6 | Torrent Pharmaceuticals Ltd. | Pharmaceuticals & Biotechnology | 4.3% | - | |
| 7 | Lupin Ltd. | Pharmaceuticals & Biotechnology | 4.2% | - | |
| 8 | Aster DM Healthcare Ltd. | Healthcare Services | 3.9% | - | |
| 9 | Biocon Ltd. | Pharmaceuticals & Biotechnology | 3.6% | - | |
| 10 | Laurus Labs Ltd. | Pharmaceuticals & Biotechnology | 3.5% | - |
Holdings Overlap with Your Portfolio
Investment Calculator
Estimate future value based on Sbi Healthcare Opportunities Fund's historical returns
⚠️ Important Disclaimer
This projection uses past returns (12% CAGR) which do NOT guarantee future performance. Actual returns may vary significantly.
💡 Why SIP works: Investing ₹10,000/month uses rupee cost averaging, buying more units when markets dip. Over 5 years, this smooths out volatility.
Returns
| 1M | 3M | 6M | 1Y | 3Y CAGR | 5Y CAGR |
|---|---|---|---|---|---|
| +3.899028695534179% | +81.37184111182523% | - | - | - | - |
Performance
This chart shows the fund's NAV growth over time.
👤Fund Manager
Fund manager information is not available for this fund.
Similar Funds
All mutual fund data is for educational purposes only. Past performance does not guarantee future returns. Mutual fund investments are subject to market risks. Read all scheme-related documents carefully before investing. Equiscale does not provide investment advice.